Small molecules in the treatment of COVID-19

S Lei, X Chen, J Wu, X Duan, K Men - Signal transduction and targeted …, 2022‏ - nature.com
The outbreak of COVID-19 has become a global crisis, and brought severe disruptions to
societies and economies. Until now, effective therapeutics against COVID-19 are in high …

Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis

T Kehrer, A Cupic, C Ye, S Yildiz, M Bouhaddou… - Cell host & …, 2023‏ - cell.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encodes several proteins
that inhibit host interferon responses. Among these, ORF6 antagonizes interferon signaling …

Anthelmintic nitazoxanide protects against experimental pulmonary fibrosis

XY Chen, YC Dong, YY Yu, M Jiang… - British Journal of …, 2023‏ - Wiley Online Library
Abstract Background and Purpose Nitazoxanide is a therapeutic anthelmintic drug. Our
previous studies found that nitazoxanide and its metabolite tizoxanide activated adenosine …

[HTML][HTML] SARS-CoV-2 variants evolve convergent strategies to remodel the host response

M Bouhaddou, AK Reuschl, BJ Polacco, LG Thorne… - Cell, 2023‏ - cell.com
SARS-CoV-2 variants of concern (VOCs) emerged during the COVID-19 pandemic. Here,
we used unbiased systems approaches to study the host-selective forces driving VOC …

Global landscape of the host response to SARS-CoV-2 variants reveals viral evolutionary trajectories

M Bouhaddou, AK Reuschl, BJ Polacco, LG Thorne… - bioRxiv, 2022‏ - biorxiv.org
ABSTRACT A series of SARS-CoV-2 variants of concern (VOCs) have evolved in humans
during the COVID-19 pandemic—Alpha, Beta, Gamma, Delta, and Omicron. Here, we used …

The FDA-approved drug nitazoxanide is a potent inhibitor of human seasonal coronaviruses acting at postentry level: effect on the viral spike glycoprotein

S Piacentini, A Riccio, S Santopolo… - Frontiers in …, 2023‏ - frontiersin.org
Coronaviridae is recognized as one of the most rapidly evolving virus family as a
consequence of the high genomic nucleotide substitution rates and recombination. The …

Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single-cell RNA sequencing

P Cohen, EJ DeGrace, O Danziger, RS Patel… - Microbiology …, 2023‏ - journals.asm.org
Single-cell RNA sequencing (scRNA-Seq) studies have provided critical insight into the
pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the …

CNBP restricts SARS-CoV2 by regulating IFN and disrupting RNA-protein condensates

K Fitzgerald, Y Chen, X Lei, Z Jiang… - Research …, 2022‏ - pmc.ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evades antiviral immunity
through the expression of viral proteins that block detection, signaling, interferon (IFN) …

Antiviral effect of thiazolides relies on mitochondrial mild uncoupling

N Hammad, C Ransy, B Pinson, J Talmasson… - bioRxiv, 2022‏ - biorxiv.org
Background Viruses are dependent on cellular energy metabolism for their replication, the
drug Nitazoxanide (Alinia) was shown to interfere with both. An effect of Alinia on cellular …

Can Nitazoxanide and/or other anti‐viral medications be a solution to long COVID? Case report with a brief literature review

DD Stewart - Clinical Case Reports, 2023‏ - pmc.ncbi.nlm.nih.gov
Key Clinical Message Findings here imply lingering of virus, SARS‐CoV‐2, in the body for
months. Thus, Nitazoxanide and/or other anti‐viral medications might be potential options to …